Steinbeck K, Turtle J R
Med J Aust. 1978 Nov 4;2(3 Suppl):35-6. doi: 10.5694/j.1326-5377.1978.tb77389.x.
Twelve patients with acromegaly were treated with bromocriptine for periods from nine to 23 months. All showed some clinical improvement. There was no significant difference in plasma growth hormone levels before and after therapy with bromocriptine, but a significant fall in plasma prolactin levels was observed after the bromocriptine therapy was commenced. The release of other pituitary hormones was not affected by bromocriptine.
12例肢端肥大症患者接受了溴隐亭治疗,治疗时间为9至23个月。所有患者均有一定的临床改善。溴隐亭治疗前后血浆生长激素水平无显著差异,但开始溴隐亭治疗后血浆催乳素水平显著下降。溴隐亭对其他垂体激素的释放没有影响。